• About us
• Contact

Advertisement

Organisation › Details

Curetis AG

Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques. To date, Curetis has raised EUR 44.3 million in an IPO on Euronext Amsterdam and Euronext Brussels and private equity funds of over EUR 63.5 million. The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia. *

 

	Start	2007-08-01 established
	End	2016-03-15 reorganised
	Group	OpGen (Group)
	Today	Curetis GmbH
	Successor	Curetis GmbH
	Industry	Unyvero molecular diagnostics platform
	Industry 2	Unyvero P50™ pneumonia cartridge
	Person	Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO)
	Person 2	Boos, Andreas (Curetis 200812– Managing Director)
	Region	Holzgerlingen
	Country	Germany
	Street	42 Max-Eyth-Str.
	City	71088 Holzgerlingen
	Tel	+49-7031-49195-10
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-12-30

Advertisement

More documents for OpGen (Group)

• [1] OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD....
• [2] OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection"....
• [3] OpGen, Inc.. (12/9/20). "Press Release: OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics". Gaithersburg, MD & Vienna....
• [4] OpGen, Inc.. (11/24/20). "Press Release: OpGen, Inc. Announces $10 Million Private Placement Priced at the Market". Gaithersburg, MD....
• [5] OpGen, Inc.. (10/28/20). "Press Release: OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators". Gaithersburg, MD & Holzgerlingen....
• [6] Sphingotec GmbH. (4/16/20). "Press Release: SphingoTec Expands Leadership Team and Appoints Achim Plum as Managing Director and Chief Commercial Officer". Hennigsdorf....
• [7] Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA....
• [8] OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD....
• [9] Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen....
• [10] OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.